Skip to main content

Adakveo 100 mg/10 mL (10 mg/mL) injection Images

Generic Name: crizanlizumab

This medication has been identified as Adakveo 100 mg/10 mL (10 mg/mL) injection. It is supplied by Novartis Pharmaceuticals Corporation.

Adakveo is used in the treatment of Sickle Cell Anemia and belongs to the drug class miscellaneous uncategorized agents. Adakveo 100 mg/10 mL (10 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Adakveo 100 mg/10 mL (10 mg/mL) injection medicine

Adakveo

Generic Name
crizanlizumab
Strength
100 mg/10 mL (10 mg/mL) injection
Availability
Prescription only
Drug Class
Miscellaneous uncategorized agents
CSA Schedule
Not a controlled drug
Labeler / Supplier
Novartis Pharmaceuticals Corporation
National Drug Code (NDC)
00078-0883

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.